New details about the way this important molecule takes on tasks beyond sensing calcium could spur the develop of new drugs for breast cancer and other diseases.
BeatProfiler, a new research tool invented by Columbia bioengineers with the help of AI, speeds and simplifies the analysis of engineered heart tissue in the laboratory.
Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
Study finds that postpartum depression is underdiagnosed in those reporting symptoms up to a year after giving birth, with Black and Asian individuals least likely to receive treatment.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Columbia biomedical engineers are collaborating with orthopedic surgeons to build a living replacement knee to be tested in clinical trials within five years.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.